[1] Dyer S, Chambers GM, de Mouzon J, et al. International committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2008, 2009 and 2010[J]. Hum Reprod,2016, 31(7): 1588–1609. doi:  10.1093/humrep/dew082
[2] The European IVF-Monitoring Consortium, European Society of Human Reproduction and Embryology, Kupka MS, et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE[J]. Hum Reprod,2016, 31(2): 233–248.
[3] International Committee for Monitoring Assisted Reproductive Technology, Adamson GD, de Mouzon J, et al. World collaborative report on in vitro fertilization, 2000[J]. Fertil Steril,2006, 85(6): 1586–1622. doi:  10.1016/j.fertnstert.2006.01.011
[4] International Committee for Monitoring Assisted Reproductive Technology, de Mouzon J, Lancaster P, et al. World collaborative report on assisted reproductive technology, 2002[J]. Hum Reprod,2009, 24(9): 2310–2320. doi:  10.1093/humrep/dep098
[5] Sullivan EA, Zegers-Hochschild F, Mansour R, et al. International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004[J]. Hum Reprod,2013, 28(5): 1375–1390. doi:  10.1093/humrep/det036
[6] Mansour R, Ishihara O, Adamson GD, et al. International committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2006[J]. Hum Reprod,2014, 29(7): 1536–1551. doi:  10.1093/humrep/deu084
[7] Adamson GD, de Mouzon J, Chambers GM, et al. International committee for monitoring assisted reproductive technology: world report on assisted reproductive technology, 2011[J]. Fertil Steril,2018, 110(6): 1067–1080. doi:  10.1016/j.fertnstert.2018.06.039
[8] Wong KM, Mastenbroek S, Repping S. Cryopreservation of human embryos and its contribution to in vitro fertilization success rates[J]. Fertil Steril,2014, 102(1): 19–26. doi:  10.1016/j.fertnstert.2014.05.027
[9] Kushnir VA, Barad DH, Albertini DF, et al. Systematic review of worldwide trends in assisted reproductive technology 2004-2013[J]. Reprod Biol Endocrinol,2017, 15(1): 6. doi:  10.1186/s12958-016-0225-2
[10] Maheshwari A, McLernon D, Bhattacharya S. Cumulative live birth rate: time for a consensus?[J]. Hum Reprod,2015, 30(12): 2703–2707.
[11] Malchau SS, Henningsen AA, Forman J, et al. Cumulative live birth rate prognosis based on the number of aspirated oocytes in previous ART cycles[J]. Hum Reprod,2019, 34(1): 171–180. doi:  10.1093/humrep/dey341
[12] McLernon DJ, Maheshwari A, Lee AJ, et al. Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178 898 women[J]. Hum Reprod,2016, 31(3): 572–581. doi:  10.1093/humrep/dev336
[13] Chambers GM, Paul RC, Harris K, et al. Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success[J]. Med J Aust,2017, 207(3): 114–118. doi:  10.5694/mja16.01435
[14] Chen LX, Li R, Ye RW. Cumulative live birth rate in vitro fertilization in China: a population-based study[J]. Chin J Reprod Health (in Chinese),2017, 28(2): 101–105.
[15] Polyzos NP, Drakopoulos P, Parra J, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ~15 000 women[J]. Fertil Steril,2018, 110(4): 661–670. doi:  10.1016/j.fertnstert.2018.04.039
[16] Raz N, Shalev A, Horowitz E, et al. Cumulative pregnancy and live birth rates through assisted reproduction in women 44-45 years of age: is there any hope?[J]. J Assist Reprod Genet,2018, 35(3): 441–447. doi:  10.1007/s10815-017-1094-0
[17] Espinós JJ, Polo A, Sánchez-Hernández J, et al. Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study[J]. Reprod BioMed Online,2017, 35(4): 417–424. doi:  10.1016/j.rbmo.2017.06.019
[18] Qiao J, Feng HL. Assisted reproductive technology in China: compliance and non-compliance[J]. Transl Pediatr,2014, 3(2): 91–97.
[19] Chinese National Department of Maternal and Child Health. Maternal and child health development report in China (2019) (in Chinese)[EB/OL]. [2019-05-27]. http://www.nhc.gov.cn/fys/s7901/201905/bbd8e2134a7e47958c5c9ef032e1dfa2.shtml.
[20] Luke B, Brown MB, Wantman E, et al. Cumulative birth rates with linked assisted reproductive technology cycles[J]. N Engl J Med,2012, 366(26): 2483–2491. doi:  10.1056/NEJMoa1110238
[21] Smith ADAC, Tilling K, Nelson SM, et al. Live-birth rate associated with repeat in vitro fertilization treatment cycles[J]. JAMA,2015, 314(24): 2654–2662. doi:  10.1001/jama.2015.17296
[22] Karimzadeh M, Salsabili N, Akbari Asbagh F, et al. Psychological disorders among iranian infertile couples undergoing Assisted Reproductive Technology (ART)[J]. Iran J Public Health,2017, 46(3): 333–341.
[23] Ramezanzadeh F, Aghssa MM, Abedinia N, et al. A survey of relationship between anxiety, depression and duration of infertility[J]. BMC Womens Health,2004, 4(1): 9. doi:  10.1186/1472-6874-4-9
[24] Moragianni VA, Penzias AS. Cumulative live-birth rates after assisted reproductive technology[J]. Curr Opin Obstet Gynecol,2010, 22(3): 189–192. doi:  10.1097/GCO.0b013e328338493f
[25] Wu F, Liu F, Guan YC, et al. A nomogram predicting clinical pregnancy in the first fresh embryo transfer for women undergoing in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments[J]. J Biomed Res,2019, 33(6): 422–429.
[26] Broekmans FJ, Knauff EAH, te Velde ER, et al. Female reproductive ageing: current knowledge and future trends[J]. Trends Endocrinol Metab,2007, 18(2): 58–65. doi:  10.1016/j.tem.2007.01.004
[27] te Velde ER, Pearson PL. The variability of female reproductive ageing[J]. Hum Reprod Update,2002, 8(2): 141–154. doi:  10.1093/humupd/8.2.141
[28] van der Steeg JW, Steures P, Eijkemans MJC, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women[J]. Hum Reprod,2008, 23(2): 324–328.
[29] Jensen TK, Scheike T, Keiding N, et al. Fecundability in relation to body mass and menstrual cycle patterns[J]. Epidemiology,1999, 10(4): 422–428. doi:  10.1097/00001648-199907000-00014
[30] Rosenbaum M, Leibel RL. The role of leptin in human physiology[J]. N Engl J Med,1999, 341(12): 913–915. doi:  10.1056/NEJM199909163411211
[31] Yuan C, Liu XQ, Mao YD, et al. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study[J]. J Biomed Res,2016, 30(3): 197–202.
[32] Craciunas L, Gallos I, Chu J, et al. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis[J]. Hum Reprod Update,2019, 25(2): 202–223. doi:  10.1093/humupd/dmy044
[33] Gallos ID, Khairy M, Chu J, et al. Optimal endometrial thickness to maximize live births and minimize pregnancy losses: Analysis of 25, 767 fresh embryo transfers[J]. Reprod BioMed Online,2018, 37(5): 542–548. doi:  10.1016/j.rbmo.2018.08.025
[34] Palermo G, Joris H, Devroey P, et al. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte[J]. Lancet,1992, 340(8810): 17–18. doi:  10.1016/0140-6736(92)92425-F
[35] Honoré GM, Holden AEC, Schenken RS. Pathophysiology and management of proximal tubal blockage[J]. Fertil Steril,1999, 71(5): 785–795. doi:  10.1016/S0015-0282(99)00014-X
[36] Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility? The importance of hydrosalpinx fluid[J]. Hum Reprod,2002, 17(5): 1141–1145. doi:  10.1093/humrep/17.5.1141